Potential Market for Motion Sickness

Department of Defense 
  • Estimated 1 million units per year at $12 per unit = 12 million per year
Civilian 
  • Approximately 11% of the US population experience motion sickness for an average of 12.8 days per year (“patient days”)
  • Of this population, 54% use medication to control symptoms
  • Assuming INSCOP captures a 60% share of this market, approximately 145 million patient days
  • Estimated $2 per day ($12 unit cost provides 6 days of treatment) = $290 million per year
*Based on a market study conducted by the prior sponsor

© 2019 Repurposed Therapeutics, Inc.